Skip to main content
Rashmi Verma, MD, Oncology, Little Rock, AR, UC Davis Medical Center

RashmiVermaMDFACP

Oncology Little Rock, AR

Hematologic Oncology

Physician

Dr. Verma is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Verma's full profile

Already have an account?

  • Office

    4018 W. Capitol Ave.
    Winthrop P. Rockefeller Cancer Institute, Seventh Floor
    Little Rock, AR 72205
    Phone+1 501-686-8530
    Fax+1 501-686-8365
  • Is this information wrong?

Education & Training

  • Texas Tech University Health Sciences Center at Lubbock
    Texas Tech University Health Sciences Center at LubbockFellowship, Hematology and Medical Oncology, 2013 - 2016
  • Cooper Medical School of Rowan University/Cooper University Hospital
    Cooper Medical School of Rowan University/Cooper University HospitalResidency, Internal Medicine, 2011 - 2012
  • University of South Dakota
    University of South DakotaResidency, Internal Medicine, 2009 - 2011
  • Delhi University College of Medical Sciences
    Delhi University College of Medical SciencesClass of 1994

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2011 - 2024
  • TX State Medical License
    TX State Medical License 2015 - 2024
  • NY State Medical License
    NY State Medical License 2019 - 2021
  • AR State Medical License
    AR State Medical License 2018 - 2020
  • NJ State Medical License
    NJ State Medical License 2012 - 2013
  • SD State Medical License
    SD State Medical License 1900 - 2012
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Chief Fellow, Hematology and Oncology Texas Tech University, 2013-2016
  • Texas Society of Clinical Oncology 2014 Poster Texas Society of Clinical Oncology, 2014
  • ASCO poster 2014 American Society of Clinical Oncology, 2014

Publications & Presentations

PubMed

Journal Articles

  • Cancer testis antigens:Potential new targets for lung cancer  
    MirandolaL., RiazJ., VermaR, Journal of Clinical Oncology
  • Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer  
    Verma R., Riaz J., alJournal of Clinical Oncology
  • Sex-driven differences in immunological responses: challenges and opportunities for the immunotherapies of the third millennium  
    Mirandola L1, Wade R, Verma R, Pena C, Hosiriluck N, Figueroa JA, Cobos E, Jenkins MR, Chiriva-Internati M, Int Rev Immunol
  • Join now to see all

Books/Book Chapters

Abstracts/Posters

  • Galectin 3C Inhibits Tumor Growth and Increases the Anticancer Activity of Taxol in vitro Murine Model of Ovarian Cancer
    Rashmi Verma, Texas Clinical Society San Antonio, San Antonio
  • . Effect of the novel galectin-3 blocker, Gal3M, on the efficacy and reduction of toxicity of proteosome inhibitors for the treatment of multiple myeloma
    Riaz J., Verma R., Mirandola L et al, ASCO, e abstract
  • Effect of galectin-3 inhibition on drug resistance, motility, invasion, and angiogenic potential in ovarian cancer.
    Verma R, Riaz J, ASCO, e abstract, 1/1/2014
  • Join now to see all

Other

Press Mentions

  • Colon and Rectal Cancer on the Rise in Young Adults
    Colon and Rectal Cancer on the Rise in Young AdultsMarch 9th, 2024

Professional Memberships

Hospital Affiliations